These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25768030)

  • 1. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder.
    Jakobsson J; Bjerke M; Sahebi S; Isgren A; Ekman CJ; Sellgren C; Olsson B; Zetterberg H; Blennow K; Pålsson E; Landén M
    J Psychiatry Neurosci; 2015 Jul; 40(4):250-8. PubMed ID: 25768030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment.
    Rolstad S; Jakobsson J; Sellgren C; Isgren A; Ekman CJ; Bjerke M; Blennow K; Zetterberg H; Pålsson E; Landén M
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1091-8. PubMed ID: 26024928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders.
    Johansson V; Jakobsson J; Fortgang RG; Zetterberg H; Blennow K; Cannon TD; Hultman CM; Wetterberg L; Landén M
    Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):391-402. PubMed ID: 28039552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes.
    Isgren A; Sellgren C; Ekman CJ; Holmén-Larsson J; Blennow K; Zetterberg H; Jakobsson J; Landén M
    Brain Behav Immun; 2017 Oct; 65():195-201. PubMed ID: 28483660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls.
    Zhang R; Song J; Isgren A; Jakobsson J; Blennow K; Sellgren CM; Zetterberg H; Bergen SE; Landén M
    Transl Psychiatry; 2020 Feb; 10(1):58. PubMed ID: 32066700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
    Wennström M; Surova Y; Hall S; Nilsson C; Minthon L; Hansson O; Nielsen HM
    PLoS One; 2015; 10(8):e0135458. PubMed ID: 26270969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.
    Orhan F; Schwieler L; Fatouros-Bergman H; Malmqvist A; Cervenka S; Collste K; Flyckt L; Farde L; Sellgren CM; Piehl F; ; Engberg G; Erhardt S
    Acta Psychiatr Scand; 2018 Nov; 138(5):432-440. PubMed ID: 30132802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
    Malmeström C; Axelsson M; Lycke J; Zetterberg H; Blennow K; Olsson B
    J Neuroimmunol; 2014 Apr; 269(1-2):87-9. PubMed ID: 24582001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased endothelial and macrophage markers are associated with disease severity and mortality in scrub typhus.
    Otterdal K; Janardhanan J; Astrup E; Ueland T; Prakash JA; Lekva T; Abraham OC; Thomas K; Damås JK; Mathews P; Mathai D; Aukrust P; Varghese GM
    J Infect; 2014 Nov; 69(5):462-9. PubMed ID: 24995849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
    Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
    Kester MI; Teunissen CE; Sutphen C; Herries EM; Ladenson JH; Xiong C; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
    Alzheimers Res Ther; 2015 Sep; 7(1):59. PubMed ID: 26383836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.
    Hellwig K; Kvartsberg H; Portelius E; Andreasson U; Oberstein TJ; Lewczuk P; Blennow K; Kornhuber J; Maler JM; Zetterberg H; Spitzer P
    Alzheimers Res Ther; 2015 Dec; 7():74. PubMed ID: 26698298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glial marker YKL-40 is decreased in synucleinopathies.
    Olsson B; Constantinescu R; Holmberg B; Andreasen N; Blennow K; Zetterberg H
    Mov Disord; 2013 Nov; 28(13):1882-5. PubMed ID: 23847144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YKL-40 is elevated in morbidly obese patients and declines after weight loss.
    Hempen M; Kopp HP; Elhenicky M; Höbaus C; Brix JM; Koppensteiner R; Schernthaner G; Schernthaner GH
    Obes Surg; 2009 Nov; 19(11):1557-63. PubMed ID: 19633900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
    Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
    J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
    Antonell A; Mansilla A; Rami L; Lladó A; Iranzo A; Olives J; Balasa M; Sánchez-Valle R; Molinuevo JL
    J Alzheimers Dis; 2014; 42(3):901-8. PubMed ID: 25024322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral inflammatory markers associated with brain volume reduction in patients with bipolar I disorder.
    Tsai SY; Sajatovic M; Hsu JL; Chung KH; Chen PH; Huang YJ
    Acta Neuropsychiatr; 2022 Aug; 34(4):191-200. PubMed ID: 34924065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders.
    Xing Y; Shepherd N; Lan J; Li W; Rane S; Gupta SK; Zhang S; Dong J; Yu Q
    Brain Behav Immun; 2017 Oct; 65():161-172. PubMed ID: 28487203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum markers in early-stage and locally advanced melanoma.
    Lugowska I; Kowalska M; Fuksiewicz M; Kotowicz B; Mierzejewska E; Koseła-Paterczyk H; Szamotulska K; Rutkowski P
    Tumour Biol; 2015 Nov; 36(11):8277-85. PubMed ID: 26002577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.